Literature DB >> 6200574

Studies on the use of antimitotic drugs entrapped within liposomes and of their action on a human glioma cell line.

G Firth, A S Oliver, R O McKeran.   

Abstract

The optimal conditions have been determined for producing the maximum incorporation within liposomes of two cell cycle-specific antimitotic drugs (bleomycin and vincristine) used in the treatment of human cerebral gliomas. Under these conditions the subsequent rate of release of these two drugs was studied in vitro. Neither cell fusion nor endocytosis could be demonstrated between liposomes of the size distribution used in these experiments (0.1-15 micron) and a human glioma cell line (U.251-MG) using a variety of marker techniques. Dose-response curves were similar for the two drugs whether free or entrapped within liposomes when applied to this cell line. These results suggest that drugs entrapped within liposomes may be useful as a potential depot preparation in the treatment of human gliomas.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200574     DOI: 10.1016/0022-510x(84)90192-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Application of radioimmunoassay to monitor treatment of human cerebral gliomas with bleomycin entrapped within liposomes.

Authors:  G B Firth; M Firth; R O McKeran; J Rees; P Walter; D Uttley; V Marks
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

Review 2.  Interstitial chemotherapy for brain tumors: review.

Authors:  T Tomita
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

3.  A potential application for the intracerebral injection of drugs entrapped within liposomes in the treatment of human cerebral gliomas.

Authors:  R O McKeran; G Firth; S Oliver; D Uttley; S O'Laoire
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 4.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.